Company Monitoring Page for Immunogen

latest headlines for company on cafepharma

Lilly reunites with ImmunoGen to expand into ADCs, paying $13M upfront and $1.7B on the back end
Fierce Biotech
Tue, 02/15/22 - 10:35 am
Tags:
Eli Lilly, Immunogen, antibody-drug conjugate
ImmunoGen lines up FDA filing as antibody-drug conjugate shrinks tumors in pivotal trial
Fierce Biotech
Tue, 11/30/21 - 10:29 am
Tags:
Immunogen, mirvetuximab soravtansine, ovarian cancer, FDA, antibody-drug conjugate
After weathering failure, rejection and layoffs, ImmunoGen touts a new 'breakthrough' drug in its comeback plan
Endpoints
Mon, 10/5/20 - 10:57 am
Tags:
Immunogen, FDA, IMGN632, blastic plasmacytoid dendritic cell neoplasm
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
Fierce Biotech
Thu, 06/27/19 - 11:37 am
Tags:
Immunogen, R&D, layoffs
A delicate balancing act for Immunogen
EP Vantage
Tue, 05/21/19 - 09:33 am
Tags:
Immunogen, mirvetuximab soravtansin, Jazz Pharmaceuticals, IMGN779, IMGN632
FDA tells ImmunoGen to run a second phase 3, sinking stock
Fierce Biotech
Wed, 05/15/19 - 10:38 am
Tags:
Immunogen, mirevtuximab soravtansine, ovarian cancer, clinical trials
ImmunoGen Plunges After Phase III Ovarian Cancer Treatment Fails to Hit PFS Endpoint
BioSpace
Fri, 03/1/19 - 10:16 am
Tags:
Immunogen, ovarian cancer, clinical trials, mirvetuximab soravtansine
ImmunoGen Waits to Leap "Forward"
Motley Fool
Sat, 11/10/18 - 12:46 pm
Tags:
Immunogen, earnings
Synaffix Adds Antibody Drug Conjugate Veteran John Lambert to Scientific Advisory Board
CP Wire
Mon, 05/14/18 - 09:29 am
Tags:
Synaffix, Immunogen, antibody-drug conjugate
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
CP Wire
Fri, 04/27/18 - 09:57 am
Tags:
Immunogen, mirvetuximab soravtansine, ovarian cancer, platinum-resistant ovarian cancer
Thu, 04/26/18 - 07:56 pm
Tags:
Immunogen, mirvetuximab soravtansine, ovarian cancer, platinum-resistant ovarian cancer
3 Biotech Stocks That Soared This Week
Motley Fool
Sun, 02/18/18 - 10:09 am
Tags:
Alkermes, Immunogen, Sorrento Therapeutics
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
Tags:
ASH, Bluebird Bio, LentiGlobin, Ziopharm Oncology, Bellicum, BPX-501, Spark Therapeutics, SPK-8011, Biomarin, BMN 270, Juno Therapeutics, CAR-T, Novartis, Geron, imetelstat, Immunogen, IMGN632, IMGN779
Jazz, ImmunoGen partner on hematology, oncology drug development
BioPharma Dive
Wed, 08/30/17 - 11:46 pm
Tags:
Jazz Pharmaceuticals, Immunogen, oncology, hematology, drug development
Why ImmunoGen, Inc. Jumped Higher Today
Motley Fool
Tue, 07/25/17 - 12:01 am
Tags:
Immunogen, anetumab ravtansine, Bayer, mesothelioma
5 Best Biotech Stocks of 2017 So Far
Motley Fool
Mon, 06/26/17 - 09:41 am
Tags:
biotech, Alnylam, Puma Biotechnology, Immunogen, Sangamo BioSciences, Calitera
Sanofi beefs up cancer drug pipeline, paying cash hungry ImmunoGen $30M for full rights to oncology portfolio
Endpoints
Tue, 05/30/17 - 10:40 am
Tags:
Sanofi, Immunogen, oncology, M&A, isatuximab, Multiple Myeloma
ImmunoGen’s new CEO retrenches, axing 65 staffers and looking to thin pipeline
Endpoints
Fri, 09/30/16 - 09:43 am
Tags:
Immunogen, layoffs
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Fri, 05/20/16 - 11:36 am
Tags:
Boston, biotech, ASCO 2016, Ariad Pharmaceuticals, Immunogen, Ziopharm, Vertex Pharmaceuticals, Tokai, Infinity Pharmaceuticals, Momenta, Merrimack, Tesaro, Syndax, Kyropharm, Foundation Medicine, Cerulean Pharma
8 Biotech Stocks Under $10 Making Big Moves Higher
TheStreet.com
Sun, 03/20/16 - 01:16 pm
Tags:
Dicerna, Novadaq Technologies, Idera Pharmaceuticals, Versartis, ProNai, Immunogen, Medgenic, Inotek

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.